Pharmacovigilance and Risk Management Strategies 2016

Discuss opportunities, challenges, and practical aspects of managing risk in the context of benefits, for medical product safety and pharmacovigilance.

返回 Agenda

Welcome and Opening Remarks

Session Chair(s)

Barbara Lopez Kunz, MBA, MS, MSc

Director | Advisor | CEO

United States

William Gregory, PhD

Senior Director, Safety and Risk Management

Pfizer Inc, United States

Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP

Strategy

Consultant, United Kingdom

Welcome and Opening Remarks

Pharmacovigilance and Risk Management Strategies 2016

Welcome and Opening Remarks

Session Chair(s)

Barbara Lopez Kunz, MBA, MS, MSc

William Gregory, PhD

Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP

获得信息并保持参与